Demographic, Clinical, and Histopathologic Characteristics of Arm B (CI Plus 18F-Fluciclovine PET; n = 79)
| Characteristic | Data |
|---|---|
| Mean age (y) | 61.6 (SD, 7.6) |
| Median PSA at PET scan (ng/mL) | 0.33 (range, 0.02–31.00) |
| Gleason score (n) | |
| 3 + 3 (grade group 1) | 8 (10.1%) |
| 3 + 4 (grade group 2) | 27 (34.2%) |
| 4 + 3 (grade group 3) | 23 (29.1%) |
| ⩾4 + 4 (grade groups 4 and 5) | 21 (26.6%) |
| Primary tumor stage (n) | |
| T1–T2 | 37 (46.8%) |
| T3–T4 | 42 (53.2%) |
| Extracapsular extension (n) | 36 (45.6%) |
| Seminal vesicle invasion (n) | 24 (30.4%) |
| Margin-positive (n) | 34 (43.0%) |
| Node-positive (n) | 15 (19.0%) |
| Ongoing ADT at PET* (n) | 12 (15.4%) |
| Mean duration on ADT before PET (d) | 40 (SD, 31) |
| Median prostatectomy-to-CI interval (y) | 1.6 (range, 0.0–11.3) |
| Median prostatectomy-to-PET interval (y) | 1.7 (range, 0.2–11.5) |
↵* n = 78 patients.